Ticker Details
Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$4.4B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.75 | 3.30%
Avg Daily Range (30 D):	$2.69 | 2.73%
Avg Daily Range (90 D):	$3.98 | 3.48%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	1.35M
Avg Daily Volume (90 D):	1.09M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	1,437
Avg Institutional Trade:	$4.51M
Avg Institutional Trade (30 D):	$4.97M
Avg Institutional Trade (90 D):	$5.63M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$8.82M
Avg Closing Trade (30 D):	$16.15M
Avg Closing Trade (90 D):	$15.61M
Avg Closing Volume:	126.71K

News

Jul 21, 2026 @ 8:58 PM CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Inv... Source: Bragar Eagel & Squire, P.C.

Jul 14, 2026 @ 8:53 PM Celcuity Announces FDA Approval of REVTORPYKâ„Â... Source: Celcuity Inc.

Jun 4, 2026 @ 2:13 AM Celcuity Inc. Announces Pricing of Upsized Public ... Source: Na

Apr 27, 2026 @ 10:18 PM Why Celcuity Stock Popped on Monday Source: Eric Volkman

Mar 27, 2026 @ 12:05 AM Why Celcuity Stock Popped Today Source: Eric Volkman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.91	$-.97	$-.98
Diluted EPS	$-3.91	$-.97	$-.98
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-192.89M	$-52.84M	$-50.97M
Operating Income / Loss	$-186.57M	$-50.51M	$-49.2M
Cost of Revenue
Net Cash Flow	$128.71M	$-20.51M	$91.45M
PE Ratio